Position in SCYX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,843,268
-$3,084,068 QoQ
Shares Held
944,292
-0.0% QoQ
Ownership
9.49%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#1
of 39 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GREAT POINT PARTNERS LLC holds $16,415,268 across 2 Drug Manufacturers - Specialty & Generic names. SCYX ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
700,000 | $12,572,000 | |
| 2 | SCYX |
Scynexis Inc
This page
|
944,292 | $3,843,268 |
All Filings in SCYX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,589,596 | 4,076,068 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $3,843,268 | 944,292 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,927,336 | 7,554,347 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||